daily glp 1 injection New clinical trial data from Eli Lilly shows its GLP-1 weight loss pill can reduce body weight by up to 11% over time. ABC News medical correspondent Dr. Darien Sutton joins Linsey Davis to GLP-1 drugs: the weight loss

Description

(30) Magruder et al

The first major commercial success from this development was semaglutide , marketed by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity

Despite the contradictory data regarding kidney outcomes, two surrogate outcomes benefit the most from combined therapy: the decline in eGFR slope and the reduction in urinary albumin-to-creatinine ratio

For instance, research has investigated microneedle arrays loaded with GLP-1 analogues, demonstrating potential for controlled release and therapeutic effect in experimental settings